Ensystex, Inc. – Trademark Portfolio
Entity Type: 03
Ensystex, Inc. holds 52 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 46 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 6 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include THOR, ZYTHOR, EXTERRA, PROTHOR, and ACCUTHOR. The owner is based in Fayetteville, NC.
2713 Breezewood Ave.
Fayetteville, NC 28303
Showing of trademarks Trademarks
Trademark Classifications
Ensystex, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Ensystex, Inc. have?
Ensystex, Inc. has 52 U.S. trademarks filed with the USPTO. Of these, 6 registered, 36 abandoned, 10 cancelled.
What trademark classes does Ensystex, Inc. file in?
Ensystex, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 37 (Building & Construction), Class 9 (Computers & Electronics), Class 8 (Hand Tools), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Ensystex, Inc.'s most well-known trademarks?
Ensystex, Inc.'s registered trademark portfolio includes well-known marks such as THOR, ZYTHOR, EXTERRA, PROTHOR, and ACCUTHOR. These are among 6 currently registered trademarks in the portfolio.
What is Ensystex, Inc.'s trademark registration success rate?
Ensystex, Inc. has a 12% trademark registration rate, with 6 out of 52 resolved applications resulting in successful registration. Currently, 0 applications are pending review.